University of Southern California
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Southern California sits in the top decile of US sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count).
University of Southern California: 617 sponsored US clinical trials, 97 recruiting.
University of Southern California sponsors 617 registered US clinical trials on ClinicalTrials.gov, 97 of them currently recruiting, and 361 completed. 31 of these trials are in Phase 3-4 (later-stage) and 173 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
University of Southern California ranks in the top decile of sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
361 of 466 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
617 total, page 4 of 13
Nicotine and Cannabis Vape Labeling Experiment - Spring 2025
NCT06919276
Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)
NCT07568444
Additional Mailed FIT Kits
NCT06805370
Randomized Trial of Follow-up to Mailed FIT Kits
NCT06805383
Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver Disease
NCT05623501
Continuous Glucose Monitoring in Prediabetes
NCT06472297
FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer
NCT06338657
Financial Incentives and Recruitment to the APT Webstudy
NCT06033066
Cognitive Behavioral Immersion: A Randomized Control Trial of Peer-Based Coaching in the Metaverse
NCT06418997
Influencer Marketing: a Survey-based Experiment Among Adolescents
NCT06501937
Effects of Heart Rate Oscillations During Meditation on Plasma Biomarkers of Alzheimer's Disease
NCT06210035
Incentives for Influenza Vaccination
NCT06300242
Barbed Suture vs Non-Barbed Closure for Emergency Exploratory Laparotomy RCT
NCT06043414
Acute Plasma Abeta Responses to Stress
NCT05521919
Prostate Resection After Microwave Ablation (PRAMA)
NCT06128525
Pre-Visit Positive Imagery in Reducing Dental Anxiety
NCT06058533
eMOTION Formative Study
NCT06125964
Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers
NCT06374251
Active Seating System to Lessen Sedentariness in Older Adults: In-home Testing Phase
NCT05510297
Influencer E-Cigarette and Cannabis Marketing: a Survey-Based Experiment Among Adolescents
NCT06919263
Long COVID-19 Syndrome Lifestyle Intervention Study
NCT05836402
Guiding Aging Long-Term Opioid Therapy Users Into Safer Use Patterns
NCT05808127
The Effects of Music Listening on Anxiety and Agitation in People With Mild and Moderate Cognitive Impairment
NCT05858541
Rates and Risk Factors of Contact Between the OTX-TIC Intracameral Ocular Implant and Corneal Endothelium
NCT05835141
Influencer Marketing: a Survey-based Experiment
NCT06433466
A Pilot Study Comparing Telehealth and In-Person Therapy Service Delivery Following NICU Discharge
NCT06893003
Virtual Reality in Pediatric Dentistry
NCT05585905
Stress Radiography for Pelvic Ring Injuries
NCT05876871
AESOPS Trial 2 (AESOPS-2): Availability of Opioid Harm
NCT04758637
Heart Rate and Breathing Effects on Attention and Memory
NCT05602220
COVID-19 Booster Incentives
NCT05648773
Precision Vaccine Promotion in Underserved Populations
NCT05537441
Double-Blinded Randomized Controlled Study Investigating the Efficacy of Exparel (Liposomal Bupivacaine) for Postoperative Pain Relief in Mandibular Third Molar Extractions
NCT05374499
Robotic Radical Nephroureterectomy Delphi Consensus
NCT05373966
Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor
NCT04840862
Telemedicine Continuous Remote Monitoring of Adults With Uncontrolled Diabetes Mellitus
NCT05161793
Here, My Voice 2 Voice Lessons Pilot
NCT05336747
Automated Stress Detection and Restoration in Office Workers
NCT05242523
Effects of e-Cigarettes on Perceptions and Behavior - Substudy 2
NCT05958966
Efficacy of a Sleep Hygiene Toolkit for Patients in ARU
NCT05541692
Helping Hypertension Patients to Interpret Blood Pressure Readings and Motivate Blood Pressure Control
NCT04485637
Improving Safe Antibiotic Prescribing in Telehealth
NCT05138874
The Role of Transcutaneous Electrical Nerve Stimulation (TENS) for Menstrual Pain Relief
NCT05178589
Therapeutic Intervention Supporting Development From NICU to 6 Months for Infants Post Hypoxic-Ischemic Encephalopathy
NCT05130528
Transportation Assistance Program for Liver Transplant
NCT05080595
Efficacy of PuraSinus Versus Bioresorbable Nasal Dressings
NCT04970966
Sonographic Measurement of Intraneural Blood Flow in the Median Nerve
NCT05057754
Smartphone App to Improve Physical Activity in Older Adults With MCI/Mild Dementia
NCT04950998
Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations
NCT06471686
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
NCT04773392
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 83 |
| Phase 2 | 90 |
| Phase 3 | 9 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the University of Southern California pipeline
97 recruiting of 617 indexed (16% open); 361 completed (59%).
Phase mix: 31 late (III/IV) vs 173 early (I/II) (early-phase heavy).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Southern California: open-pipeline peers nationwide
Peers matched on 617 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 617 trials (± recruiting share)
- Baylor College of Medicine · 616 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 16% open enrollment (± trial volume)
- Youngstown State University · 16% recruiting · 19 trials
- Roswell Park Cancer Institute · 16% recruiting · 365 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- University of Oregon · 16% recruiting · 63 trials
Related
What to do with this University of Southern California page
617 registered trials is a research-attention snapshot, not an endorsement of University of Southern California or any single study.
- 97 of University of Southern California's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Southern California studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Southern California pipeline card: 617 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.